Published online Apr 27, 2024. doi: 10.4240/wjgs.v16.i4.988
Revised: February 18, 2024
Accepted: April 3, 2024
Published online: April 27, 2024
Processing time: 117 Days and 0.2 Hours
The 21st century has started with several innovations in the medical sciences, with wide applications in health care management. This development has taken in the field of medicines (newer drugs/molecules), various tools and technology which has completely changed the patient management including abdominal surgery. Surgery for abdominal diseases has moved from maximally invasive to minimally invasive (laparoscopic and robotic) surgery. Some of the newer medicines have its impact on need for surgical intervention. This article focuses on the development of these emerging molecules, tools, and technology and their impact on present surgical form and its future effects on the surgical intervention in gastroenterological diseases.
Core Tip: This editorial discusses the effect of newer medicines, emerging tools and technology, and their impact on surgery for gastrointestinal diseases and its future. Whether surgery is going to remain in its present form or will come up in a new makeover or vanish completely in the future?
